|
|
Other links at Articles > Business of Medicine |
| 1. |
Merck Agrees to Pay $4.85 Bln in Vioxx Settlement
|
|
|
Merck & Co has agreed to pay $4.85 billion to settle claims that its painkiller Vioxx caused heart attacks and strokes in thousands of users, the drugmaker said on Friday. Reuters Health Information
|
| 2. |
U.S. Medicare Bill With Big HMO Cuts Faces Senate Vote
|
|
|
A bill with about $13 billion in cuts to private health insurers in Medicare is expected to face a vote in the U.S. Senate as early as Thursday, as backers work off momentum from an unexpected victory earlier this week. Reuters Health Information
|
| 3. |
Brown to Allow Partial Free Vote on Embryo Law
|
|
|
Gordon Brown said on Tuesday that Labour MPs will have a free vote on three "ethical" parts of proposed legislation on embryo research after reports said some cabinet ministers could resign over the issue. Reuters Health Information
|
| 4. |
FDA Warns Glaxo on Cancer Drug Promotions
|
|
|
GlaxoSmithKline PLC sent misleading letters to health professionals touting its breast cancer drug Tykerb, U.S. health officials said in a letter released on Monday. Reuters Health Information
|
| 5. |
Lilly Settles Zyprexa Case With Alaska for $15 Mln
|
|
|
Eli Lilly and Co on Wednesday said it agreed to pay $15 million to settle a lawsuit by the state of Alaska accusing it of concealing possible side effects from Zyprexa, its widely used schizophrenia medicine. Reuters Health Information
|
|
|
